ARCA biopharma Inc Watch

from 8-K 3 pages ARCA Biopharma, Inc. Second Amendment to Retention Bonus Letter

from 8-K 3 pages ARCA Biopharma, Inc. Second Amendment to Retention Bonus Letter

from 8-K 12 pages Certain Identified Information Marked With [***] Has Been Excluded From This Exhibit Because It Is Not Material and Is of the Type That the Registrant Treats as Private and Confidential. ARCA Biopharma, Inc. Consulting Agreement

from 8-K 9 pages Separation Agreement and Release

from 8-K 7 pages Lock-Up Agreement

from 8-K 12 pages Support Agreement

from 8-K 25 pages Subscription Agreement

from 8-K 13 pages Support Agreement

from 8-K 3 pages First Amendment to Office Lease Agreement

from 8-K 4 pages ARCA Biopharma, Inc. Amendment to Retention Bonus Letter

from 8-K 4 pages ARCA Biopharma, Inc. Amendment to Retention Bonus Letter

from 8-K 4 pages Memorandum

from 8-K 4 pages Memorandum

from 8-K 13 pages This Letter (This “Agreement”) Constitutes the Agreement Between (A) ARCA Biopharma, Inc. (“Company”) and (B) Cable Car Capital LLC and Each of the Other Related Persons (As Defined Below) Set Forth on the Signature Pages to This Agreement (Collectively, the “CCC Signatories”). Company and the CCC Signatories Are Collectively Referred to as the “Parties.” the CCC Signatories and Each Affiliate (As Defined Below) and Associate (As Defined Below) of Each CCC Signatory Are Collectively Referred to as the “CCC Group.” 1. Board Matters

from 10-Q 13 pages Assignment Agreement for Patent Rights

from 10-Q 18 pages 2.duties. You Shall Render Exclusive Services as a Full-Time Employee to the Company as Its Chief Financial Officer and Shall Report to the Company’s Chief Executive Officer. Your Responsibilities, Title, Working Conditions, Duties, Reporting Relationship and/or Any Other Aspect of Your Employment May Be Changed, Added to or Eliminated During Your Employment at the Sole Discretion of the Company. During the Term of Your Employment Hereunder, You Shall Devote Your Best Efforts and Your Full Business Time, Skill and Attention to the Performance of Your Duties on Behalf of the Company; Provided, However, That the Company Recognizes That You May Continue to Provide Reasonably Acceptable, as Determined by the Company, Transition Services to Globeimmune, Inc. for a Period of Up to [12 Months] After the Start Date. Your Primary Responsibility in This Position Will Be to Provide Overall Leadership for the Financial Operations of the Company, and in This Role You Will Collaborate Closely With the CEO, COO and Other Members of the Senior Leadership Team. 3. Compensation

from 8-K 5 pages Amendment No. 1 to Capital on Demand™ Sales Agreement

from 8-K 9 pages ARCA Biopharma, Inc. Restricted Stock Unit Grant Notice

from 8-K 8 pages ARCA Biopharma, Inc. Restricted Stock Unit Grant Notice

from 8-K 13 pages ARCA Biopharma, Inc. Stock Option Grant Notice